From their update after Q3:
• Improved operating performance
o EBITDA in Q3 of $6.4m
o FY21 YTD EBITDA up 79% to $21.2m
So ebitda should be more around 27m at a guess if Q4 was like Q3
Result and guidance could be a little messy with impacts of jobkeeper/ lockdowns etc But things are definitely improving with their issues being sorted out.
Might be another 6 months before they resume a dividend, we'll have to see.
Share price could easily recover to 40 cents plus once a few more investors realise this has turned a corner and the business is improving again.
CEO was interviewed on coffee microcaps quite awhile ago- just search for it on youtube.
Ann: ENTERS JV - IN VITRO DIAGNOSTIC BLOOD BANK REAGENTS IN CHINA, page-14
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.005(1.22%) |
Mkt cap ! $686.9M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.5¢ | 41.0¢ | $457.1K | 1.112M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 417437 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 399983 | 7 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| PGC (ASX) Chart |